Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight
NCT04779697Phase 1Completed
- Sponsor
- Yale University
- Start
- Feb 2021
- Primary completion
- Nov 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of semaglutide in obesity (2 arms), sponsored by Yale University. Primary endpoints: Change in Craving Score at 12 weeks, Change in Hunger Score at 12 weeks and 1 more. Started Feb 2021; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04779697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04779697.